Literature DB >> 7865519

Does rapidity of development of transplant coronary artery disease portend a worse prognosis?

S Z Gao1, S A Hunt, J S Schroeder, E Alderman, I R Hill, E B Stinson.   

Abstract

We postulated that transplant coronary artery disease with rapid progression to more than 50% stenosis within a 1-year interval may have a different prognosis from transplant coronary artery disease with a more indolent rate of progression. Annual coronary angiograms of 139 consecutive patients who underwent transplantation between January 1968 and February 1990 who survived at least 1 year after transplantation and in whom angiographically apparent transplant coronary artery disease developed were included in the study. Of this group, 45 patients progressed from a normal angiogram to the presence of 50% or greater stenosis in one or more major vessels within 1 year (fulminant group); 94 did not (indolent group). Mean posttransplantation follow-up time was 5.3 +/- 4.1 years for patients with fulminant progression of disease and 6.6 +/- 3.7 years for those with indolent progression. A highly significant difference was found in the time-related incidence of ischemic events (myocardial infarction, congestive heart failure, sudden death, and retransplantation) between the indolent and the fulminant groups after initial detection of transplant coronary artery disease. At 1, 3, and 5 years after initial detection of transplant coronary artery disease, 50%, 33%, and 16% of patients in the fulminant group and 89%, 70%, and 60% of patients in the indolent group were free of ischemic events (p < 0.0001). The fulminant group of patients had a mean of 2.9 +/- 1.5 rejection episodes, and the indolent group a mean of 2.3 +/- 1.4 episodes (p = 0.02) during the first year after transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7865519

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

Review 1.  [Heart transplantation--state of the art today].

Authors:  B M Meiser; W von Scheidt; M Weis; D Böhm; F Kur; J Koglin; H Reichenspurner; P Uberfuhr; B Reichart
Journal:  Herz       Date:  1997-10       Impact factor: 1.443

2.  Improvement of reversible ischemia in severe post-transplantation coronary artery disease.

Authors:  R Delgado; B Radovancević; A Springer; K L Gould; O H Frazier
Journal:  Tex Heart Inst J       Date:  1998

3.  Risk factors of cardiac allograft vasculopathy.

Authors:  Bożena Szyguła-Jurkiewicz; Wioletta Szczurek; Mariusz Gąsior; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-12-30

Review 4.  The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy.

Authors:  Maciej Dyrbuś; Mariusz Gąsior; Bożena Szyguła-Jurkiewicz; Piotr Przybyłowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-04-03       Impact factor: 1.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.